Stock analysis, trade plans, and proprietary indicators by Trend Edge.
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. Read full Trend Edge analysis →
Sector: Healthcare
Industry: Biotechnology
Exchange: NASDAQ
IPO Date: August 8, 2017
Headquarters: 2 Headquarters Plaza, Morristown, NJ, United States, 07960
Founder-Led: Yes — Neil Desai (Founder & Director)
Key Metrics
Current Price
$4.70
Market Cap
$252M
Float
18.1M
Shares Outstanding
49.5M
P/E (Forward)
2.66
Price/Sales (TTM)
35.30
vs. Analyst Target
+38.3% to analyst PT
Profit Margin
-288.26%
Operating Margin (TTM)
-1601.12%
Revenue (TTM)
$7.1M
Dividend Rate
None
Analyst Target Price
$6.50 (3 analysts)
Financial History
Annual Revenue & Earnings History
Year
Revenue
Net Income
Gross Profit
EBITDA
2020
$14.6M
-$3.5M
-$428,000
-$2.5M
2021
$1.1M
-$110M
-$18.6M
-$37.0M
2022
$15.2M
-$60.5M
-$18.8M
-$58.8M
2023
$24.4M
-$65.8M
-$27.4M
-$71.8M
2024
$26.0M
-$63.7M
-$28.1M
-$64.6M
2025
$7.1M
-$20.6M
$6.4M
-$114M
Recent Quarterly Revenue & Net Income
Quarter
Revenue
Net Income
Jun 2025
N/A
-$52.6M
Sep 2025
N/A
-$17.7M
Dec 2025
N/A
-$23.3M
Mar 2026
N/A
-$22.2M
Ownership & Float
Insider Ownership
13.8%
Institutional Ownership
72.5%
Short Float
4.5%
% of All Funds Holding
0.67%
Number of Funds Holding
55
Current Moving Averages
Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.
Timeframe
SMA
Value
Trend Context
Weekly
10-Week SMA
$3.84
Near-term / short-term trend
Weekly
40-Week SMA
$2.75
Medium-term trend
Weekly
80-Week SMA
$2.49
Cyclical trend (business cycle)
Weekly
200-Week SMA
$4.78
Secular trend (multi-year)
Monthly
10-Month SMA
$2.92
Near-term monthly trend
Monthly
20-Month SMA
$2.54
Medium-term monthly trend
Monthly
40-Month SMA
$3.41
Secular monthly trend
Volume Shelves — Support & Resistance
Trend Edge identifies volume shelves: price zones where historically elevated trading volume
creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative
volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.
Price Level
Type
Volume Ratio
Age
$1.90
support
7.94x
6 months ago
Historical Earnings Reactions (34 events)
Timeframe
Avg Return
Median
Win Rate
Best
Worst
Gap
-0.20%
0.00%
44.12%
6.10%
-13.66%
1 Day
1.33%
0.13%
50.00%
19.61%
-9.76%
1 Week
3.98%
2.53%
58.82%
39.37%
-8.57%
2 Weeks
1.63%
1.51%
57.58%
22.83%
-65.35%
1 Month
1.47%
0.00%
48.48%
89.74%
-66.01%
Next earnings: May 14, 2026
Seasonality & Day-of-Week Patterns
Monthly Seasonality
Month
Avg Return
Win Rate
Samples
Jan
17.2%
50.0%
8
Feb
0.4%
37.5%
8
Mar
-18.2%
11.1%
9
Apr
-2.4%
44.4%
9
May
17.9%
87.5%
8
Jun
-5.3%
37.5%
8
Jul
-2.5%
37.5%
8
Aug
3.1%
62.5%
8
Sep
0.3%
62.5%
8
Oct
-9.3%
12.5%
8
Nov
7.8%
62.5%
8
Dec
-8.5%
50.0%
8
Day-of-Week Tendencies
Day
Avg Return
Win Rate
Samples
Monday
-0.25%
47.8%
389
Tuesday
0.17%
47.9%
426
Wednesday
0.08%
45.0%
422
Thursday
0.22%
42.4%
415
Friday
-0.13%
45.1%
415
Top Institutional Holders
Institutional holder breakdown coming soon.
Total institutional ownership: 72.5%
Insider Transactions — Smart Summary
Total insider ownership: 13.8%
Founder-led management: Neil Desai (Founder & Director)
12-Month Insider Activity Summary
Total Filings
9
Net Value
-$2.6M
Net Shares Change
98,470
% of Float
0.5%
C-Suite Filings
9
Clusters Detected
2
Key Insiders
Name
Title
Net Value
Filings
Activity
Lennon David James
CHIEF EXECUTIVE OFFICER
-$1.1M
4
4 sell
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
-$890,614.242
2
2 sell
BALL BRYAN
Chief Technical Operations Officer and SVP, Manufacturing Operations
-$635,051.412
3
3 sell
Transaction Clusters
Period
Filings
Insiders
Net Value
Seniority
2026-03-10 – 2026-03-10
3
3
-$31,533.869
3 C-suite
2026-04-03 – 2026-04-17
6
3
-$2.6M
6 C-suite
Significant Filings
Date
Insider
Title
Net Value
Price After
2026-04-17
Giacobello Scott M.
CHIEF FINANCIAL OFFICER
-$882,029.14
Transaction at $4.03, now +16.5%
2026-04-15
BALL BRYAN
Chief Technical Operations Officer and SVP, Manufacturing Operations
Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Whitehawk Therapeutics, Inc.
(WHWK) powered by Claude Opus — Anthropic's most capable AI model.
The analysis covers five layers:
technical analysis (near-term, medium-term, cyclical, and secular trend, momentum,
volume shelf support and resistance, breakout and breakdown signals),
qualitative analysis (business model, competitive moat, sector dynamics),
insider sentiment (buy and sell signals from executive and director transactions),
share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and
fundamental analysis (valuation, revenue growth, profit margin, earnings quality).
AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit,
stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward.
Whether you are building a long position, initiating a short, or looking for a reversal setup,
AI Consult identifies the highest-probability signal from the current trend.